Td Private Client Wealth LLC Biomarin Pharmaceutical Inc Transaction History

Td Private Client Wealth LLC

$3.58 Trillion
Q4 2024

A detailed history of Td Private Client Wealth LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Td Private Client Wealth LLC holds 636 shares of BMRN stock, worth $41,244. This represents 0.0% of its overall portfolio holdings.

Number of Shares

636

Previous 510 24.71%

Holding current value

$41,244

Previous $35.8 Million 16.61%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$61.93 - $70.49 $7,803 - $8,881	126 Added 24.71%	636 $41.8 Million
Q3 2024 Nov 18, 2024	BUY	$69.02 - $93.84 $12,837 - $17,454	186 Added 57.41%	510 $35.8 Million
Q2 2024 Aug 14, 2024	BUY	$74.43 - $92.22 $24,115 - $29,879	324 New	324 $26.7 Million
Q1 2024 Aug 16, 2024	BUY	$83.81 - $99.0 $9,051 - $10,692	108 Added 76.6%	249 $21.7 Million
Q4 2023 Aug 16, 2024	BUY	$76.22 - $98.51 $1,829 - $2,364	24 Added 20.51%	141 $13.6 Million
Q3 2023 Aug 16, 2024	BUY	$85.07 - $94.48 $935 - $1,039	11 Added 10.38%	117 $10.4 Million
Q2 2023 Aug 16, 2024	BUY	$86.68 - $100.3 $2,253 - $2,607	26 Added 32.5%	106 $9.19 Million
Q1 2023 Aug 16, 2024	BUY	$87.74 - $117.27 $1,228 - $1,641	14 Added 21.21%	80 $7.78 Million
Q4 2022 Aug 16, 2024	BUY	$80.93 - $108.63 $809 - $1,086	10 Added 17.86%	66 $6.83 Million
Q1 2022 Aug 16, 2024	SELL	$74.28 - $92.69 $1,039 - $1,297	-14 Reduced 20.0%	56 $4.32 Million
Q4 2021 Aug 16, 2024	BUY	$71.72 - $91.47 $2,151 - $2,744	30 Added 75.0%	70 $6.19 Million
Q3 2021 Aug 16, 2024	SELL	$74.77 - $85.47 $21,234 - $24,273	-284 Reduced 87.65%	40 $3.09 Million
Q2 2021 Aug 16, 2024	BUY	$75.51 - $84.79 $830 - $932	11 Added 29.73%	48 $4.01 Million
Q1 2021 Aug 16, 2024	BUY	$74.73 - $90.69 $1,120 - $1,360	15 Added 68.18%	37 $2.79 Million
Q4 2020 Aug 16, 2024	BUY	$72.61 - $90.2 $290 - $360	4 Added 22.22%	22 $1.93 Million
Q3 2020 Aug 16, 2024	BUY	$71.87 - $131.03 $718 - $1,310	10 Added 125.0%	18 $1.37 Million
Q2 2020 Aug 16, 2024	SELL	$79.55 - $124.22 $2,147 - $3,353	-27 Reduced 77.14%	8 $987,000
Q4 2019 Aug 16, 2024	SELL	$64.27 - $86.37 $18,574 - $24,960	-289 Reduced 89.2%	35 $2.96 Million

Others Institutions Holding BMRN

# of Institutions

635

Shares Held

183M

Call Options Held

2.07M

Put Options Held

1.72M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.

Account

Td Private Client Wealth LLC Biomarin Pharmaceutical Inc Transaction History